Study Stopped
Participants no longer receiving intervention
Photorefractive Keratectomy for Severe Anisometropia and Isoametropia Associated With Amblyopia
1 other identifier
interventional
200
1 country
1
Brief Summary
Photorefractive keratectomy (PRK) with excimer laser has been used successfully to treat myopia, hyperopia, and astigmatism in adults for over 35 years. Children with high refractive errors that go untreated will develop severe amblyopia. PRK can normalize high refractive errors and potentially improve the visual acuity in affected children. The purpose of this study is to investigate whether children with high anisometropia or isoametropia with amblyopia that are nonresponsive to standard therapy and receive PRK develop better longterm visual acuity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2001
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedFirst Submitted
Initial submission to the registry
July 19, 2018
CompletedFirst Posted
Study publicly available on registry
August 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedDecember 8, 2025
December 1, 2025
23.7 years
July 19, 2018
December 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Visual acuity
Snellen equivalent
10 years
Secondary Outcomes (2)
Refractive error
10 years
Corneal clarity
10 years
Study Arms (1)
Photorefractive keratectomy
OTHERThe children will undergo PRK in the affected eye(s) using previously derived formulas for PRK.
Interventions
Eligibility Criteria
You may qualify if:
- Children aged 2 to 17 with significant anisometropia or isoametropia and amblyopia that have failed traditional treatment for at least 6 months.
- Anisometropic group:
- The anisometropia must be at least 3.00 diopters.
- The amblyopic eye best corrected visual acuity must be at least 2 lines worse than the fellow eye in verbal children
- Isoametropic group
- Myopia must be at least -4.00 diopters in both eyes
- Hyperopia must be at least +4.00 diopters in both eyes
- Astigmatism must be at least +2.50 diopters in both eyes.
You may not qualify if:
- History of significant corneal abnormality that, in the investigator's opinion, may limit visual rehabilitation.
- History of known collagen disorder
- History of known corneal ectasia
- History of previous herpes simplex keratitis
- Corneal thickness of less than 450u
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Children's Hospital
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Evelyn Paysse, MD
Baylor College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Ophthalmology and Pediatrics
Study Record Dates
First Submitted
July 19, 2018
First Posted
August 2, 2018
Study Start
January 1, 2001
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
December 8, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share